Lv3
335 积分 2021-06-21 加入
Combining antibody-drug conjugates with immune checkpoint inhibitors: A new paradigm for breast cancer therapy
57分钟前
待确认
Next-Generation Checkpoint Combinations: Optimizing PD-(L)1–Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings
23小时前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
22天前
已完结